Pivotal Ventures Shifts Strategy: Entering Private Equity for Growth
Expanding the Investment Horizon
To achieve true parity with their male counterparts, senior women in the U.S. private equity sector would need to oversee an additional $1.6 trillion in assets. Addressing this systemic imbalance, Melinda French Gates’ investment firm, Pivotal Ventures, officially moved beyond its traditional venture capital roots this past September to enter the private equity landscape.
The firm’s inaugural commitments highlight a dual-pronged strategy. Through Invidia Capital Management, led by Jo Natauri, the firm acquired WIN—a platform specializing in fertility, maternity, and menopause benefits. Simultaneously, Pivotal backed Daphne Dufresne’s Awani Capital, which recently acquired a residential roofing platform. These moves signal a shift toward both specialized healthcare impact and the broader empowerment of female capital allocators.
The Commercial Case for Women’s Health
For Jo Natauri, the acquisition of WIN was not a mission-driven mandate but a calculated business decision. The firm sought a robust healthcare entity, and WIN’s track record—spanning three decades with a proven clinical model—made it an ideal candidate. Unlike many startups that rely on pitch decks highlighting unmet needs, WIN arrived with a history of serving over 900,000 families and established revenue streams.
"We didn’t set out to make women’s health our first investment," Natauri notes. "We set out to find a great healthcare business, and WIN met our criteria."
This approach highlights a critical evolution in the market: the transition of women’s health from a niche mission to a scalable commercial enterprise. By focusing on employers and health plans as primary payers, companies like WIN are sidestepping the volatility of consumer-only models, provided they can prove high utilization rates rather than just enrollment statistics.
Bridging the Capital Gap
Pivotal’s decision to diversify stems from a stark reality: venture capital represents only 20% of the global private investment market. By limiting its scope to early-stage funding, Pivotal was effectively ignoring 80% of the investment universe. Erin Harkless Moore, managing director of investments at Pivotal, emphasizes that this expansion is essential for long-term impact.
- Strategic Scaling: Pivotal has now backed 27 female-led funds managing nearly $6.7 billion.
- Performance Focus: The firm maintains that its strategy is not about lowering standards but about reframing the metrics that predict success.
- Market Access: By backing firms like Awani Capital, Pivotal is ensuring that women have a seat at the table where major economic decisions are made, regardless of the specific industry.
A New Standard for Founders
The success of these investments offers a clear lesson for founders: capital is increasingly flowing toward businesses with proven clinical models and existing payment structures. As Pivotal continues to screen for firms that avoid extractive practices, the focus remains on long-term value creation. Whether in healthcare or industrial services, the goal is to identify managers who can professionalize and scale durable businesses, proving that gender-diverse leadership is a catalyst for superior commercial performance.